SIGNIA THERAPEUTICS RECEIVES A €1.7 MILLION DEEPTECH DEVELOPMENT GRANT FROM BPIFRANCE

With a total budget of €3.7 million over 36 months, the supported program aims to scale up the SIGNATURA drug discovery platform